Fungi are a source of natural bioactive compounds that offer therapeutic potential in the prevention of viral diseases and for the improvement of human immunomodulation. Here, we made a brief review of the current findings on fungi as producers of protease inhibitors and studies on the relevant candidate fungal bioactive compounds that can offer immunomodulatory activities as potential therapeutic agents of coronaviruses in the future.
A discussion on the potential role of TCM herbs for the treatment of COVID-19.
Although it is common practice to apply the originally European name ‘Ganoderma lucidum’ to all commerical reishi products. Taxonomists have made a case that there is a difference between East Asian strains G. lingzhi and the European G. lucidum strains. G. lucidum contains less triterpenic acids than G. lingzhi.
https://www.sciencedirect.com/science/article/pii/S0031942216300413
Hsue-Yin Hsu – School of Technology for Medical Sciences, Kaohsiung Medical College, Kaohsiung, Taiwan
Shi-Long Lian – Department of Radiotherapy, Kaohsiung Medical College, Kaohsiung, Taiwan
Chun-Ching Lin – School of Pharmacy, Kaohsiung Medical College, Kaohsiung, Taiwan
http://www.worldscinet.com/ajcm/18/1801n02/S0192415X90000095.html
Published on August 20, 2013 vol. 110 no. 34 13809-13814 by PNAS (Proceedings of the National Academy of Sciences of the United States of America)
Thulasi G. Pillai and K. K. Janardhanan – Amala Cancer Research Centre, Thrissur 680 555, India
Veena P. Salvi, Dharmendra Kumar Maurya, and Cherupally Krishnan Krishnan Nair – Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai 400 085, India